Search research articles
Contact Us
Filters
Showing results (441-450 of 465) with videos related to
Page
of 47
Sort By:
The International Journal on Drug Policy
|
August 4, 2025
Patient preferences for simplified hepatitis C testing modalities among people at risk of hepatitis C infection in Australia: the SELECT study
Annabelle Stevens, Jake Abbott, Loriate Gribbin, et al.
The Lancet. Gastroenterology & Hepatology
|
February 17, 2024
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions
Alison D Marshall, Alex R Willing, Abe Kairouz, et al.
The Journal of Investigative Dermatology
|
June 13, 2002
Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients
Steffen Emmert, Hanoch Slor, David B Busch, et al.
Drug and Alcohol Dependence
|
June 30, 2022
Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study
Alice Wheeler, Heather Valerio, Evan B Cunningham, et al.
The International Journal on Drug Policy
|
March 20, 2026
Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P study
Anna Conway, Jason Grebely, Shane Tillakeratne, et al.
The International Journal on Drug Policy
|
June 19, 2017
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study
Jason Grebely, Olav Dalgard, Evan B Cunningham, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 16, 2023
Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs
Qinglu Cheng, Evan B Cunningham, Sophy Shih, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 14, 2019
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study
Andreea A Artenie, Evan B Cunningham, Gregory J Dore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2019
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
May 18, 2018
Burn Surgeon and Palliative Care Physician Attitudes Regarding Goals of Care Delineation for Burned Geriatric Patients
Holly B Cunningham, Shannon A Scielzo, Paul A Nakonezny, et al.
Page
of 47
Search research articles
Search
Showing results (441-450 of 465) with videos related to
Sort By:
Page
of 47
The International Journal on Drug Policy
|
August 4, 2025
Patient preferences for simplified hepatitis C testing modalities among people at risk of hepatitis C infection in Australia: the SELECT study
Annabelle Stevens, Jake Abbott, Loriate Gribbin, et al.
The Lancet. Gastroenterology & Hepatology
|
February 17, 2024
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions
Alison D Marshall, Alex R Willing, Abe Kairouz, et al.
The Journal of Investigative Dermatology
|
June 13, 2002
Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients
Steffen Emmert, Hanoch Slor, David B Busch, et al.
Drug and Alcohol Dependence
|
June 30, 2022
Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study
Alice Wheeler, Heather Valerio, Evan B Cunningham, et al.
The International Journal on Drug Policy
|
March 20, 2026
Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P study
Anna Conway, Jason Grebely, Shane Tillakeratne, et al.
The International Journal on Drug Policy
|
June 19, 2017
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study
Jason Grebely, Olav Dalgard, Evan B Cunningham, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 16, 2023
Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs
Qinglu Cheng, Evan B Cunningham, Sophy Shih, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 14, 2019
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study
Andreea A Artenie, Evan B Cunningham, Gregory J Dore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2019
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
May 18, 2018
Burn Surgeon and Palliative Care Physician Attitudes Regarding Goals of Care Delineation for Burned Geriatric Patients
Holly B Cunningham, Shannon A Scielzo, Paul A Nakonezny, et al.
Page
of 47